(Q45747716)

15 December 2017

title

Oral ganciclovir treatment in chronic hepatitis B virus infection: a pilot study (English)

1 reference

15 December 2017

1 reference

1 reference

1 reference

Hadziyannis SJ

1

1 reference

15 December 2017

Manesis EK

series ordinal

2

1 reference

15 December 2017

Papakonstantinou A

series ordinal

3

1 reference

15 December 2017

publication date

1 August 1999

1 reference

15 December 2017

published in

Journal of Hepatology

1 reference

15 December 2017

volume

31

1 reference

15 December 2017

issue

2

1 reference

15 December 2017

page(s)

210-214

1 reference

15 December 2017

Inhibition of HBV DNA replication by ganciclovir in patients with AIDS

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

Combination antiviral therapy controls severe post-liver transplant recurrence of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

Attempted resolution of acute recurrent hepatitis B in a transplanted liver allograft by the administration of ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

Ganciclovir treatment of active hepatitis B virus infection in a heart transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus— and cytomegalovirus-seropositive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antivirals.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

A sensitive PCR assay system for the quantitation of viral genome equivalents: human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

Antiviral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

1 reference

7 January 2021

Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980215-3

7 January 2021

10.1016/S0168-8278(99)80215-3

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

10453931

1 reference

15 December 2017